Follow the JOINN Laboratories (China) Co., Ltd. stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, JOINN Laboratories (China) Co., Ltd. has published 6 reports. Market capitalisation: €18.3bn. The latest transaction was filed on 7 May 2026 (Purchase). Among the most active insiders: Feng Yuxia. Every trade is openly available.
Analysts rate JOINN Laboratories (China) Co., Ltd. Buy (bullish), based on 5 analysts. Average price target: HK$22.74.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
JOINN Laboratories (China) Co., Ltd. es una empresa centrada en la investigación y el desarrollo de fármacos, así como en servicios de pruebas preclínicas y clínicas. Cotiza en la Bolsa de Hong Kong.